CCL Pharmaceuticals (Pvt.) Ltd, a leading name in the pharmaceutical industry, has attained another significant milestone with the acquisition of a PIC/S (Pharmaceutical Inspection Co-operation Scheme) approved plant in Sundar Industrial Estate, Lahore. This development reinforces the company’s unwavering dedication to growth, innovation, and enhancing global access to medicines. CCL, a leading global pharmaceutical organization from Pakistan, has presence in 24 markets spanning Southeast Asia, the Middle East, Africa, the Commonwealth of Independent States, and South Asia.
This acquisition holds the promise of a positive impact on both the economy and the broader community. The newly acquired plant will play a pivotal role in manufacturing innovative and life-saving medicines, addressing unmet patient needs. Simultaneously, it will contribute to job creation and strengthen Pakistan’s position in the global pharmaceutical market. With this acquisition, CCL Pharmaceuticals joins the highly exclusive list of pharmaceutical manufacturers from Pakistan having a PIC/S certified facility.
Central to CCL’s mission is the steadfast commitment to “enabling a Happy Healthy Life,” resonating throughout its operations. This strategic acquisition exemplifies CCL’s continuous pursuit of pushing the boundaries of possibility. By integrating cutting-edge technology and industry expertise, the company strives to deliver pharmaceutical solutions that align with the evolving needs of patients worldwide.
The CCL leadership team officially took over the plant and engaged with employees to reinforce the company’s vision, values, and culture. During this interaction, CEO Ali Masood expressed gratitude to sponsors and team members for their patient and people-centric approach throughout the acquisition process. Ali highlighted, “This PIC/S approved plant acquisition demonstrates our commitment to fostering innovation and growth, improving global access to medicines, and addressing unmet patient needs. This milestone will further support us in our mission of enabling a Happy Healthy Life.”
With this acquisition, CCL now has three manufacturing facilities, two in Pakistan and one in Vietnam. With nearly 60 years in the industry, CCL stands resolute in its commitment to innovation, access to medicines, and sustainability, while offering a diverse and inclusive environment for its employees.
